People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

30 Jun 2015
Change (% chg)

$-0.03 (-0.79%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

O'Dwyer, Donal 

Mr. Donal P. O'Dwyer, BE, MBA, is Non-Executive Independent Director of Mesoblast Ltd. Donal O’Dwyer has over 25 years of experience as a senior executive in the global cardiovascular and medical devices industries. From 1996 to 2003, he worked for Cordis Cardiology, the cardiology division of Johnson & Johnson’s Cordis Corporation, initially as its President (Europe) and as its worldwide President from 2000. In his role, Mr O’Dwyer led Cordis through the launch of the revolutionary Cypher drug eluting coronary stent technology, and saw the company take over number one market share of coronary stents worldwide. Prior to joining Cordis, he worked for 12 years with Baxter Healthcare, rising from plant manager in Ireland to President of the Cardiovascular Group, Europe (now Edwards Lifesciences). Mr O’Dwyer is a qualified civil engineer and has an MBA. He has been Non-executive Director, Cochlear Limited (since 2005); Non-executive Director, Atcor Medical Holdings Limited (since 2004); and Non-executive Director, Fisher & Paykel Healthcare (since 2013). He was Non-executive Director, Sunshine Heart (from 2004 to 2013). He is Chairman of the Remuneration and Nomination Committee and Member of the Audit & Risk Committee.

Basic Compensation

Total Annual Compensation, AUD 159,667
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 14,769
Fiscal Year Total, AUD 174,436

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Brian Jamieson


Silviu Itescu


Paul Hodgkinson


Charlie Harrison


William Burns


Donal O'Dwyer

As Of  29 Jun 2014
Search Stocks